233 related articles for article (PubMed ID: 21809123)
1. Pyruvate dehydrogenase inhibition by the inflammatory cytokine TNFα contributes to the pathogenesis of pulmonary arterial hypertension.
Sutendra G; Dromparis P; Bonnet S; Haromy A; McMurtry MS; Bleackley RC; Michelakis ED
J Mol Med (Berl); 2011 Aug; 89(8):771-83. PubMed ID: 21809123
[TBL] [Abstract][Full Text] [Related]
2. The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted.
Bonnet S; Rochefort G; Sutendra G; Archer SL; Haromy A; Webster L; Hashimoto K; Bonnet SN; Michelakis ED
Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11418-23. PubMed ID: 17596340
[TBL] [Abstract][Full Text] [Related]
3. Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis.
McMurtry MS; Bonnet S; Wu X; Dyck JR; Haromy A; Hashimoto K; Michelakis ED
Circ Res; 2004 Oct; 95(8):830-40. PubMed ID: 15375007
[TBL] [Abstract][Full Text] [Related]
4. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.
Meloche J; Courchesne A; Barrier M; Carter S; Bisserier M; Paulin R; Lauzon-Joset JF; Breuils-Bonnet S; Tremblay É; Biardel S; Racine C; Courture C; Bonnet P; Majka SM; Deshaies Y; Picard F; Provencher S; Bonnet S
J Am Heart Assoc; 2013 Jan; 2(1):e005157. PubMed ID: 23525442
[TBL] [Abstract][Full Text] [Related]
5. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
He RL; Wu ZJ; Liu XR; Gui LX; Wang RX; Lin MJ
Cell Physiol Biochem; 2018; 49(1):172-189. PubMed ID: 30134231
[TBL] [Abstract][Full Text] [Related]
6. Dexamethasone induces apoptosis in pulmonary arterial smooth muscle cells.
Price LC; Shao D; Meng C; Perros F; Garfield BE; Zhu J; Montani D; Dorfmuller P; Humbert M; Adcock IM; Wort SJ
Respir Res; 2015 Sep; 16(1):114. PubMed ID: 26382031
[TBL] [Abstract][Full Text] [Related]
7. Krüppel-like factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension.
Courboulin A; Tremblay VL; Barrier M; Meloche J; Jacob MH; Chapolard M; Bisserier M; Paulin R; Lambert C; Provencher S; Bonnet S
Respir Res; 2011 Sep; 12(1):128. PubMed ID: 21951574
[TBL] [Abstract][Full Text] [Related]
8. Dehydroepiandrosterone inhibits the Src/STAT3 constitutive activation in pulmonary arterial hypertension.
Paulin R; Meloche J; Jacob MH; Bisserier M; Courboulin A; Bonnet S
Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1798-809. PubMed ID: 21890685
[TBL] [Abstract][Full Text] [Related]
9. Fluoxetine protects against monocrotaline-induced pulmonary arterial hypertension: potential roles of induction of apoptosis and upregulation of Kv1.5 channels in rats.
Zhai FG; Zhang XH; Wang HL
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):850-6. PubMed ID: 19298536
[TBL] [Abstract][Full Text] [Related]
10. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
Cheng G; Wang X; Li Y; He L
Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to the development of pulmonary arterial hypertension.
Guo D; Gu J; Jiang H; Ahmed A; Zhang Z; Gu Y
J Mol Cell Cardiol; 2016 Feb; 91():179-87. PubMed ID: 26774701
[TBL] [Abstract][Full Text] [Related]
12. Glycogen synthase kinase 3beta contributes to proliferation of arterial smooth muscle cells in pulmonary hypertension.
Sklepkiewicz P; Schermuly RT; Tian X; Ghofrani HA; Weissmann N; Sedding D; Kashour T; Seeger W; Grimminger F; Pullamsetti SS
PLoS One; 2011 Apr; 6(4):e18883. PubMed ID: 21533110
[TBL] [Abstract][Full Text] [Related]
13. Serum-glucocorticoid regulated kinase 1 regulates macrophage recruitment and activation contributing to monocrotaline-induced pulmonary arterial hypertension.
Xi X; Liu S; Shi H; Yang M; Qi Y; Wang J; Du J
Cardiovasc Toxicol; 2014 Dec; 14(4):368-78. PubMed ID: 24825325
[TBL] [Abstract][Full Text] [Related]
14. Enhanced Ca(2+)-sensing receptor function in idiopathic pulmonary arterial hypertension.
Yamamura A; Guo Q; Yamamura H; Zimnicka AM; Pohl NM; Smith KA; Fernandez RA; Zeifman A; Makino A; Dong H; Yuan JX
Circ Res; 2012 Aug; 111(4):469-81. PubMed ID: 22730443
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy of AAV1.SERCA2a in monocrotaline-induced pulmonary arterial hypertension.
Hadri L; Kratlian RG; Benard L; Maron BA; Dorfmüller P; Ladage D; Guignabert C; Ishikawa K; Aguero J; Ibanez B; Turnbull IC; Kohlbrenner E; Liang L; Zsebo K; Humbert M; Hulot JS; Kawase Y; Hajjar RJ; Leopold JA
Circulation; 2013 Jul; 128(5):512-23. PubMed ID: 23804254
[TBL] [Abstract][Full Text] [Related]
16. Deficiency of NOX1/nicotinamide adenine dinucleotide phosphate, reduced form oxidase leads to pulmonary vascular remodeling.
Iwata K; Ikami K; Matsuno K; Yamashita T; Shiba D; Ibi M; Matsumoto M; Katsuyama M; Cui W; Zhang J; Zhu K; Takei N; Kokai Y; Ohneda O; Yokoyama T; Yabe-Nishimura C
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):110-9. PubMed ID: 24233492
[TBL] [Abstract][Full Text] [Related]
17. PAR-2 inhibition reverses experimental pulmonary hypertension.
Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
[TBL] [Abstract][Full Text] [Related]
18. PGC1α-mediated mitofusin-2 deficiency in female rats and humans with pulmonary arterial hypertension.
Ryan JJ; Marsboom G; Fang YH; Toth PT; Morrow E; Luo N; Piao L; Hong Z; Ericson K; Zhang HJ; Han M; Haney CR; Chen CT; Sharp WW; Archer SL
Am J Respir Crit Care Med; 2013 Apr; 187(8):865-78. PubMed ID: 23449689
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-221-3p promotes pulmonary artery smooth muscle cells proliferation by targeting AXIN2 during pulmonary arterial hypertension.
Nie X; Chen Y; Tan J; Dai Y; Mao W; Qin G; Ye S; Sun J; Yang Z; Chen J
Vascul Pharmacol; 2019 May; 116():24-35. PubMed ID: 28694128
[TBL] [Abstract][Full Text] [Related]
20. HNRNPA2B1: RNA-Binding Protein That Orchestrates Smooth Muscle Cell Phenotype in Pulmonary Arterial Hypertension.
Ruffenach G; Medzikovic L; Aryan L; Li M; Eghbali M
Circulation; 2022 Oct; 146(16):1243-1258. PubMed ID: 35993245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
